Skip to main content
Clinical Trials/NCT06083285
NCT06083285CompletedNot Applicable

Xinjiang Medical University of Affiliated Tumour Hospital

Xinjiang Medical University1 site in 1 country76 target enrollmentStarted: February 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
76
Locations
1
Primary Endpoint
To explore the influence of CRRT nursing team management plan on the prognosis of SAKI patients.

Study Overview

Brief Summary

The implementation of CRRT nursing team management program in the treatment of SAKI can significantly reduce the incidence of adverse events and complications in CRRT nursing, which has a positive role in improving the success rate of CRRT treatment and the clinical outcome of patients.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The Guidelines for Emergency Treatment of Sepsis / Septic Shock in China (2018)[4]Diagnostic criteria for moderate sepsis; ② meets the Organization for Improving Global Kidney Disease Outcomes (KDIGO) Clinical Practice Guidelines: AKI[5]Relevant diagnostic criteria in; ③ received CRRT as indicated for CRRT; ④ in ICU for longer than 24 hours; ⑤ signed consent.

Exclusion Criteria

  • with chronic organ failure, or advanced malignancy; ② with previous history of chronic kidney disease, retrorenal urinary tract obstruction; ③ with incomplete clinical data.

Outcomes

Primary Outcomes

To explore the influence of CRRT nursing team management plan on the prognosis of SAKI patients.

Time Frame: 3-10 days

The incidence of unplanned removal of CRRT, unplanned extubation and CRRT nursing related complications in the observation group were lower than those in the control group (P \<0.05). Kaplan Meier survival curve showed that the survival rate of patients in the observation group was higher than that in the control group (P \<0.05).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Xinjiang Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xiemuziya Maimaitirexiati

Associate Chief Physician

Xinjiang Medical University

Study Sites (1)

Loading locations...

Similar Trials